Tag: Cardioprotection

In a significant clinical study (SMILE project), zofenopril was shown to reduce the long-term risk of cardiovascular mortality and morbidity in patients after a heart attack. This highlights the considerable clinical impact and unique benefits of zofenopril for specific high-risk cardiac patients.

First developed in the 1980s, GHRP-6 is a synthetic hexapeptide that acts as a potent growth hormone (GH) secretagogue, triggering the body's natural GH production. This article explores **what is the use of GHRP-6 peptide** and examines its pharmacological actions, potential benefits, side effects, and regulatory landscape based on available research.

Despite promising results in animal models suggesting potent regenerative effects and heart protection, rigorous clinical trials in humans are virtually absent. This raises significant questions about whether BPC 157 is good for your heart in a real-world, clinical setting.